WVE Wave Life Sciences Ltd.

NASDAQ
$4.35

Wave Life Sciences Ltd. (WVE) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
2
6 transactions
Insiders selling
11
47 transactions
Purchases
$82.6M
10,243,496 shares
Sales
$16.2M
1,122,704 shares
Net activity
$66.4M
purchases less sales

How much of that selling was preplanned? 98% planned / 2% discretionary

10b5-1 plan sales $15.9M 43 transactions · 1,103,525 shares
Discretionary sales $258.0K 4 transactions · 19,179 shares

Largest single sale: $1.7M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 30, 2026 .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Rawcliffe Adrian Director Sell 10b5-1 12,700 $5.29 $67.2K None left
Wagner Heidi L Director Sell 10b5-1 7,000 $6.01 $42.1K 44,930 −13.5% of holding
TAKANASHI KEN Director Sell 10b5-1 3,864 $6.01 $23.2K 20,079 −16.1% of holding
Tan Aik Na Director Sell 10b5-1 432 $6.01 $2.6K 24,968 −1.7% of holding
Buy 971,091 $6.50 $6.3M 26,975,505
Buy 2,495,623 $6.43 $16.0M 26,004,414
2 fills Buy 5,305,782 $6.08 $32.3M 23,508,791
Francis Chris 2 fills See Remarks Sell 10b5-1 33,194 $15.05 $499.6K 61,867 −34.9% of holding
BOLNO PAUL President and CEO Sell 10,480 $13.45 $141.0K 275,520 −3.7% of holding
Moran Kyle Chief Financial Officer Sell 3,588 $13.45 $48.3K 134,385 −2.6% of holding
Vargeese Chandra See Remarks Sell 3,228 $13.45 $43.4K 408,246 −0.8% of holding
Francis Chris See Remarks Sell 1,883 $13.45 $25.3K 61,867 −3% of holding
Francis Chris 2 fills See Remarks Sell 10b5-1 9,375 $16.03 $150.3K 26,295 −26.3% of holding
GSK plc 10% Owner Buy 1,470,000 $19.00 $27.9M 18,245,691
Moran Kyle 2 fills Chief Financial Officer Sell 10b5-1 50,036 $20.03 $1.0M 90,365 −35.6% of holding
Francis Chris 9 fills See Remarks Sell 10b5-1 441,031 $14.57 $6.4M 25,000 −94.6% of holding
Moran Kyle 4 fills Chief Financial Officer Sell 10b5-1 210,000 $14.77 $3.1M 139,218 −60.1% of holding
Tan Aik Na 8 fills Director Sell 10b5-1 134,218 $13.58 $1.8M 50,400 −72.7% of holding
HENRY CHRISTIAN O 4 fills Director Sell 10b5-1 93,445 $14.65 $1.4M 12,700 −88% of holding
Rawcliffe Adrian Director Sell 10b5-1 42,000 $15.00 $630.0K 12,700 −76.8% of holding
Verdine Gregory L. 2 fills Director Sell 10b5-1 20,000 $13.47 $269.5K 283,197 −6.6% of holding
CORRIGAN MARK 2 fills Director Sell 10b5-1 16,115 $13.48 $217.3K 35,330 −31.3% of holding
Wagner Heidi L 2 fills Director Sell 10b5-1 14,000 $13.50 $189.0K 44,930 −23.8% of holding
Rawcliffe Adrian Director Sell 10b5-1 16,115 $6.79 $109.4K 12,700 −55.9% of holding
Buy 1,000 $6.69 $6.7K 18,203,009

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.